Notifications can be managed in browser preferences.
As the NHS rolls out weight loss drugs like Mounjaro more widely, we’re asking whether they should be available to all who qualify, or reserved for only the most severe cases
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A major expansion of NHS weight loss treatment begins today, as GPs across England are now able to prescribe Mounjaro – an injectable drug also known as tirzepatide – for the first time.
Once limited to specialist clinics or private prescriptions, Mounjaro will now be accessible through general practice for people with severe obesity, specifically, those with a BMI over 40 and at least four related health conditions, such as type 2 diabetes, heart disease, or sleep apnoea.
